Polymyositis and dermatomyositis screening: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Polymyositis and dermatomyositis}} {{CMG}}; {{AE}} {{SSH}} ==Overview== ==Screening== *There is insufficient evidence to recommend routine screening for polymyo..." |
|||
| Line 9: | Line 9: | ||
*There is insufficient evidence to recommend routine screening for polymyositis and dermatomyositis. | *There is insufficient evidence to recommend routine screening for polymyositis and dermatomyositis. | ||
*However, patients with polymyositis and dermatomyositis must be screened for complications such as: | *However, patients with polymyositis and dermatomyositis must be screened for complications such as: | ||
** | **Assessment for malignancy initially and annually for three years | ||
Revision as of 15:07, 6 April 2018
|
Polymyositis and dermatomyositis Microchapters |
|
Differentiating Polymyositis and dermatomyositis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Polymyositis and dermatomyositis screening On the Web |
|
American Roentgen Ray Society Images of Polymyositis and dermatomyositis screening |
|
Risk calculators and risk factors for Polymyositis and dermatomyositis screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sadaf Sharfaei M.D.[2]
Overview
Screening
- There is insufficient evidence to recommend routine screening for polymyositis and dermatomyositis.
- However, patients with polymyositis and dermatomyositis must be screened for complications such as:
- Assessment for malignancy initially and annually for three years